As of today (2024-04-25), the Trailing Annual Dividend Yield of ALX Oncology Holdings is 0.00%.
The historical rank and industry rank for ALX Oncology Holdings's Dividend Yield % or its related term are showing as below:
ALXO's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59 * Ranked among companies with meaningful Dividend Yield % only.
ALX Oncology Holdings's Dividend Payout Ratio for the
three
months ended in Dec. 2023 was 0.00.
ALX Oncology Holdings's Dividends per Share for the
three
months ended in Dec. 2023 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
ALX Oncology Holdings Dividend Yield % Historical Data
The historical data trend for ALX Oncology Holdings's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ALX Oncology Holdings's Dividend Yield %
For the Biotechnology subindustry, ALX Oncology Holdings's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ALX Oncology Holdings's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ALX Oncology Holdings's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ALX Oncology Holdings's Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
ALX Oncology Holdings Dividend Yield % Related Terms
Thank you for viewing the detailed overview of ALX Oncology Holdings's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
ALX Oncology Holdings (ALX Oncology Holdings) Business Description
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALXO has been successfully added to your 